Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner

被引:75
作者
Elgendy, Mohamed [1 ]
Ciro, Marco [1 ,2 ]
Abdel-Aziz, Amal Kamal [1 ]
Belmonte, Giuseppe [3 ]
Dal Zuffo, Roberto [1 ]
Mercurio, Ciro [1 ]
Miracco, Clelia [3 ]
Lanfrancone, Luisa [1 ]
Foiani, Marco [2 ,4 ]
Minucci, Saverio [1 ,4 ,5 ]
机构
[1] European Inst Oncol, Dept Expt Oncol, IEO, I-20139 Milan, Italy
[2] IFOM Fdn Ist FIRC Oncol Mol, I-20139 Milan, Italy
[3] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
[4] Univ Milan, Dept Biosci, I-20100 Milan, Italy
[5] European Inst Oncol, Drug Dev Program, IEO, I-20139 Milan, Italy
关键词
TARGETING MCL-1; PROSTATE-CANCER; MELANOMA-CELLS; APOPTOSIS; EXPRESSION; RESISTANCE; SURVIVAL; THERAPY; INHIBITION; SABUTOCLAX;
D O I
10.1038/ncomms6637
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Mcl-1 is a unique Bcl-2 family member that plays crucial roles in apoptosis. Apoptosis-unrelated functions of Mcl-1 are however emerging, further justifying its tight regulation. Here we unravel a novel mechanism of Mcl-1 regulation mediated by the haplo-insufficient tumour suppressor Beclin 1. Beclin 1 negatively modulates Mcl-1 stability in a reciprocal manner whereby depletion of one leads to the stabilization of the other. This co-regulation is independent of autophagy and of their physical interaction. Both Beclin 1 and Mcl-1 are deubiquitinated and thus stabilized by binding to a common deubiquitinase, USP9X. Beclin 1 and Mcl-1 negatively modulate the proteasomal degradation of each other through competitive displacement of USP9X. The analysis of patient-derived melanoma cells and tissue samples shows that the levels of Beclin 1 decrease, while Mcl-1 levels subsequently increase during melanoma progression in a significant inter-dependent manner. The identified inverse co-regulation of Beclin 1 and Mcl-1 represents a mechanism of functional counteraction in cancer.
引用
收藏
页数:11
相关论文
共 37 条
[1]
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML):: evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides [J].
Aichberger, KJ ;
Mayerhofer, M ;
Krauth, MT ;
Skvara, H ;
Florian, S ;
Sonneck, K ;
Akgul, C ;
Derdak, S ;
Pickl, WF ;
Wacheck, V ;
Selzer, E ;
Monia, BP ;
Moriggl, R ;
Valent, P ;
Sillaber, C .
BLOOD, 2005, 105 (08) :3303-3311
[2]
Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21 [J].
Aita, VM ;
Liang, XH ;
Murty, VVVS ;
Pincus, DL ;
Yu, WP ;
Cayanis, E ;
Kalachikov, S ;
Gilliam, TC ;
Levine, B .
GENOMICS, 1999, 59 (01) :59-65
[3]
Mcl-1 is a potential therapeutic target in multiple types of cancer [J].
Akgul, C. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (08) :1326-1336
[4]
Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis [J].
Boisvert-Adamo, Karen ;
Longmate, Whitney ;
Abel, Ethan V. ;
Aplin, Andrew E. .
MOLECULAR CANCER RESEARCH, 2009, 7 (04) :549-556
[5]
Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance [J].
Bolesta, Elzbieta ;
Pfannenstiel, Lukas W. ;
Demelash, Abeba ;
Lesniewski, Mathew L. ;
Tobin, Megan ;
Schlanger, Simon E. ;
Nallar, Shreeram C. ;
Papadimitriou, John C. ;
Kalvakolanu, Dhan V. ;
Gastman, Brian R. .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (10) :1879-1892
[6]
Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance [J].
Bonapace, Laura ;
Bornhauser, Beat C. ;
Schmitz, Maike ;
Cario, Gunnar ;
Ziegler, Urs ;
Niggli, Felix K. ;
Schaefer, Beat W. ;
Schrappe, Martin ;
Stanulla, Martin ;
Bourquin, Jean-Pierre .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (04) :1310-1323
[7]
Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance [J].
Campbell, Kirsteen J. ;
Bath, Mary L. ;
Turner, Marian L. ;
Vandenberg, Cassandra J. ;
Bouillet, Philippe ;
Metcalf, Donald ;
Scott, Clare L. ;
Cory, Suzanne .
BLOOD, 2010, 116 (17) :3197-3207
[8]
Down-regulation of Mcl-1 by small interfering RNA sensitizes resistant melanoma cells to Fas-mediated apoptosis [J].
Chetoui, Nizar ;
Sylla, Khaoussou ;
Gagnon-Houde, Jean-Vincent ;
Alcaide-Loridan, Catherine ;
Charron, Dominique ;
Al-Daccak, Reem ;
Aoudjit, Fawzi .
MOLECULAR CANCER RESEARCH, 2008, 6 (01) :42-52
[9]
MCL-1 expression in B-cell non-Hodgkin's lymphomas [J].
Cho-Vega, JH ;
Rassidakis, GZ ;
Admirand, JH ;
Oyarzo, M ;
Ramalingam, P ;
Paraguya, A ;
McDonnell, TJ ;
Amin, HM ;
Medeiros, LJ .
HUMAN PATHOLOGY, 2004, 35 (09) :1095-1100
[10]
Structural insights into the degradation of Mcl-1 induced by BH3 domains [J].
Czabotar, Peter E. ;
Lee, Erinna F. ;
van Delft, Mark F. ;
Day, Catherine L. ;
Smith, Brian J. ;
Huang, David C. S. ;
Fairlie, W. Douglas ;
Hinds, Mark G. ;
Colman, Peter M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (15) :6217-6222